MALAT1 and bone cancer: Although MALAT1 dysregulation has been documented in numerous malignancies—such as lung, uterine, cervical, breast, colon, pancreatic, gastric, renal, bladder, and bone cancers—our study found that most treatments had little or no effect on MALAT1 expression, with only minor increases observed in some cases [65].